LT2774991T - Vaisto įvedimo sistema, skirta naudoti neurologinių sutrikimų gydymui arba diagnostikai - Google Patents

Vaisto įvedimo sistema, skirta naudoti neurologinių sutrikimų gydymui arba diagnostikai

Info

Publication number
LT2774991T
LT2774991T LTEP13001491.3T LT13001491T LT2774991T LT 2774991 T LT2774991 T LT 2774991T LT 13001491 T LT13001491 T LT 13001491T LT 2774991 T LT2774991 T LT 2774991T
Authority
LT
Lithuania
Prior art keywords
diagnosis
treatment
delivery system
drug delivery
neurological disorders
Prior art date
Application number
LTEP13001491.3T
Other languages
English (en)
Inventor
Victoria Demina
Heiko Manninga
Armin Gƶtzke
Alexander Glassmann
Original Assignee
Life Science Inkubator Betriebs Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2013/000656 external-priority patent/WO2013131644A1/en
Application filed by Life Science Inkubator Betriebs Gmbh & Co. Kg filed Critical Life Science Inkubator Betriebs Gmbh & Co. Kg
Publication of LT2774991T publication Critical patent/LT2774991T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/22042—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/22043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22071—Demonstrated in vivo effect
LTEP13001491.3T 2013-03-06 2013-03-22 Vaisto įvedimo sistema, skirta naudoti neurologinių sutrikimų gydymui arba diagnostikai LT2774991T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2013/000656 WO2013131644A1 (en) 2012-03-06 2013-03-06 A novel drug delivery system based on jcv-vlp
EP13001491.3A EP2774991B1 (en) 2013-03-06 2013-03-22 Drug delivery system for use in the treatment or diagnosis of neurological disorders

Publications (1)

Publication Number Publication Date
LT2774991T true LT2774991T (lt) 2018-03-26

Family

ID=47915420

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP13001491.3T LT2774991T (lt) 2013-03-06 2013-03-22 Vaisto įvedimo sistema, skirta naudoti neurologinių sutrikimų gydymui arba diagnostikai

Country Status (7)

Country Link
EP (2) EP3312283A1 (lt)
CY (1) CY1120278T1 (lt)
HR (1) HRP20180361T1 (lt)
LT (1) LT2774991T (lt)
NO (1) NO2774991T3 (lt)
PL (1) PL2774991T3 (lt)
SI (1) SI2774991T1 (lt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3031820A1 (en) 2014-12-08 2016-06-15 Life Science Inkubator JC Polyomavirus VLP (virus-like particle) with a targeting peptide
EP3031821A1 (en) * 2014-12-08 2016-06-15 Life Science Inkubator polyomavirus VLPs with a fusion protein
RU2682966C1 (ru) * 2018-03-20 2019-03-25 Общество С Ограниченной Ответственностью "Валента - Интеллект" Комбинации буспирона для лечения головокружения
CN111323527B (zh) * 2018-12-13 2022-12-02 湖南德米特仪器有限公司 一种用复合二维液相色谱同时测定多种精神药物的方法
CN112137994B (zh) * 2020-09-15 2022-10-14 中山大学 小分子化合物在制备抗丝状病毒药物中的应用
CN115317614B (zh) * 2022-10-14 2022-12-27 暨南大学 Adk抑制剂在制备治疗脊髓损伤的药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19543553B4 (de) 1995-11-22 2009-04-09 Deutsches Primatenzentrum Gmbh VP-Antigene des JC-Virus
EP0977596B1 (en) 1997-04-26 2004-01-21 Rpms Technology Limited Use of papovavirus capsid protein for delivery of therapeutic agents to neuronal cells
DE10131145B4 (de) * 2001-06-28 2005-07-14 Innovent E.V. Zusammensetzung zum zellspezifischen Transfer von Wirkstoffen
EP2036980A1 (de) 2007-09-14 2009-03-18 Gruber, Jens Herabregulation der Genexpression mittels Nukleinsäure-beladener virusähnlicher Partikel
CN104316696A (zh) * 2009-02-05 2015-01-28 生物基因Idecma公司 用于检测jc多瘤病毒的方法

Also Published As

Publication number Publication date
PL2774991T3 (pl) 2018-05-30
SI2774991T1 (en) 2018-04-30
CY1120278T1 (el) 2019-07-10
EP3312283A1 (en) 2018-04-25
HRP20180361T1 (hr) 2018-04-20
EP2774991B1 (en) 2017-12-06
EP2774991A1 (en) 2014-09-10
NO2774991T3 (lt) 2018-05-05

Similar Documents

Publication Publication Date Title
EP2967484A4 (en) SYSTEM AND SIGNATURES FOR MULTIMODAL PHYSIOLOGICAL STIMULATION AND EVALUATION OF BRAIN HEALTH
HUE061618T2 (hu) Vegyület szemrendellenességek kezelésére
PL2968218T3 (pl) Skojarzenie do leczenia choroby parkinsona
HK1217322A1 (zh) 用於治療眼科疾病和病症的取代的 -苯基丙胺衍生物
HK1208830A1 (en) Drug delivery device for the treatment of patients with respiratory diseases
SI2838539T1 (sl) Estrogenski derivati za uporabo pri zdravljenju nevroloških motenj
HUS2000020I1 (hu) Ciklezonid a légúti betegségek kezelésére lovaknál
HK1207860A1 (en) 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders 2--5---2h--3-
EP2968881A4 (en) APPARATUS, SYSTEMS AND METHODS FOR BRAIN MEDICATION ADMINISTRATION FOR TREATING NEUROLOGICAL CONDITIONS
IL235058A0 (en) Pharmaceutical combinations for the treatment of metabolic disorders
GB2542155B (en) Use of cannabidiol in the treatment of mental disorders
LT2774991T (lt) Vaisto įvedimo sistema, skirta naudoti neurologinių sutrikimų gydymui arba diagnostikai
EP2819741A4 (en) SOLVENT MEDICINAL IMPLANTS FOR THE INTRACOCHLEAR RELEASE OF THERAPEUTICS FOR THE TREATMENT OF EARLIER DISEASES
HUE038580T2 (hu) Hatóanyag bejuttató rendszer neurológiai rendellenességek kezelésében, vagy diagnózisában való felhasználásra
HUE051875T2 (hu) Egyláncú oligonukleotidok bõrrendellenességek orvosi kezelésében történõ alkalmazásra
PT2859896T (pt) Composições farmacêuticas para o tratamento de distúrbios musculares
HK1223041A1 (zh) 匹多莫德用於治療炎症相關疾病的用途
HK1223827A1 (zh) 用於治療眼疾病的 調節劑
PL2861568T3 (pl) Aminy trzeciorzędowe do zastosowania w leczeniu zaburzeń serca
GB201320506D0 (en) Cyclic amino compounds for the use in the treatment of cardiac disorders
PL3352777T3 (pl) Engrailed do stosowania w leczeniu uszkodzenia dna u pacjentów cierpiących na chorobę parkinsona
GB201309179D0 (en) Portamed - medical kiosk for health diagnosis and medicine dispense system